Home|Journals|Articles by Year|Audio Abstracts RSS - TOC
 

Case Report

EJMCR. 2022; 6(3): 48-51


Toxic pneumonitis induced by trastuzumab as a potentially fatal event: a case report

Raquel Fontes, Jorge Rodrigues, Camila Oliveira, Mauricio Peixoto, Ricardo Fernandes, Luisa Queiroz, Catarina Portela, Marta Almeida, Rui Nabico.




Abstract

Background: Trastuzumab is a widely used and well-tolerated drug. Pulmonary toxicity has been described; however, the low incidence, the variability at presentation, and the nonspecific characteristics often make it an exclusion diagnosis.
Case presentation: We present the case of a 62-year-old women admitted to our service with fever and shortness of breast after treatment with trastuzumab. From the study performed, no other cause was found to explain the event and the patient kept worsening until the diagnosis was established.
Conclusion: Although pneumonitis is a rare side effect of trastuzumab administration, early recognition and appropriate therapy are crucial and may be lifesaving.

Key words: breast cancer; trastuzumab; adverse reactions; pulmonary toxicity; case report






Full-text options


Share this Article



Online Article Submission
• ejmanager.com
• ojshosting.net




eJManager.com
Review(er)s Central
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.